Montreal, Canada

Andrea Richter

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andrea Richter: Innovator in Neurodegenerative Disease Research

Introduction

Andrea Richter is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and patented discoveries. Her work focuses on the identification of mutations that can lead to better diagnostic and treatment methods for these conditions.

Latest Patents

Andrea Richter holds a patent titled "Identification of arsacs mutations and methods of use therefor." This patent includes isolated spastin genes and fragments, as well as spastin proteins and their fragments. The patent also discloses altered forms of spastin, along with methods for diagnosing and treating neurodegenerative diseases. This groundbreaking work has the potential to impact the lives of many individuals affected by such conditions.

Career Highlights

Throughout her career, Andrea has demonstrated a commitment to advancing scientific knowledge and improving healthcare outcomes. Her innovative approach to research has led to the development of valuable tools and methodologies in the field of neurodegenerative disease.

Collaborations

Andrea has collaborated with notable colleagues, including James C Engert and Thomas J Hudson. These partnerships have further enriched her research and contributed to the advancement of her work.

Conclusion

Andrea Richter is a trailblazer in the field of neurodegenerative disease research, with a focus on innovative solutions that can lead to improved diagnostics and treatments. Her contributions are invaluable to the scientific community and hold promise for future advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…